LKH - Universitätsklinikum der PMU Salzburg — Salzburg

Public research footprint of LKH - Universitätsklinikum der PMU Salzburg, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Crohn Disease · Ulcerative Colitis · Multiple Myeloma · Chronic Lymphocytic Leukemia

Recently updated registry entries

NCT07499232 — A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely… (Recruiting)
NCT06710132 — Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE… (Active Not Recruiting)
NCT06208150 — A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at LKH - Universitätsklinikum der PMU Salzburg?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.